Serial Passaging of Candida albicans in Systemic Murine Infection Suggests That the Wild Type Strain SC5314 Is Well Adapted to the Murine Kidney

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lüttich, Anja ^a   Brunke, Sascha ^a,b   Hube, Bernhard ^a,b,c   Jacobsen, Ilse D ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b Center of Sepsis Control and Care   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; FUNGUS TRANSMISSION; IMMUNE RESPONSE; KIDNEY INFECTION; MOLECULAR EVOLUTION; MOUSE; MUTATION; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; EVOLUTION, MOLECULAR; FEMALE; KIDNEY; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; PHENOTYPE; SERIAL PASSAGE; TEMPERATURE;

CANDIDA; CANDIDA ALBICANS; MURINAE;

EID: 84878505557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064482     Document Type: Article

References (44)

1. Perlroth J, Choi B, Spellberg B, (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45: 321-346.
2. Eggimann P, Bille J, Marchetti O, (2011) Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 1: 37.
3. Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S, (2005) Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother 56: 532-537.
4. Pfaller MA, Diekema DJ, (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
5. Asticcioli S, Nucleo E, Perotti G, Matti C, Sacco L, et al. (2007) Candida albicans in a neonatal intensive care unit: antifungal susceptibility and genotypic analysis. New Microbiol 30: 303-307.
6. Vonk AG, Netea MG, van der Meer JW, Kullberg BJ, (2006) Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy. Expert Opin Biol Ther 6: 891-903.
7. Calderone RA, Fonzi WA, (2001) Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
8. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, et al. (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365: 54-61.
9. van Enckevort FH, Netea MG, Hermus AR, Sweep CG, Meis JF, et al. (1999) Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med Mycol 37: 419-426.
10. Barelle CJ, Priest CL, Maccallum DM, Gow NA, Odds FC, et al. (2006) Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell Microbiol 8: 961-971.
11. Hube B, (2004) From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr Opin Microbiol 7: 336-341.
12. Selmecki A, Forche A, Berman J, (2010) Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryot Cell 9: 991-1008.
13. Galhardo RS, Hastings PJ, Rosenberg SM, (2007) Mutation as a stress response and the regulation of evolvability. Crit Rev Biochem Mol Biol 42: 399-435.
14. Bougnoux ME, Diogo D, Francois N, Sendid B, Veirmeire S, et al. (2006) Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract. J Clin Microbiol 44: 1810-1820.
15. Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS, et al. (1998) Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66: 89-97.
16. Shin JH, Park MR, Song JW, Shin DH, Jung SI, et al. (2004) Microevolution of Candida albicans strains during catheter-related candidemia. J Clin Microbiol 42: 4025-4031.
17. Cowen LE, Kohn LM, Anderson JB, (2001) Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 183: 2971-2978.
18. Yan L, Zhang J, Li M, Cao Y, Xu Z, et al. (2008) DNA microarray analysis of fluconazole resistance in a laboratory Candida albicans strain. Acta Biochim Biophys Sin (Shanghai) 40: 1048-1060.
19. White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW, (1997) Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Dis 3Suppl 1: S102-109.
20. Cowen LE, Sanglard D, Calabrese D, Sirjusingh C, Anderson JB, et al. (2000) Evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 182: 1515-1522.
21. Andes D, Forrest A, Lepak A, Nett J, Marchillo K, et al. (2006) Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob Agents Chemother 50: 2374-2383.
22. Schroppel K, Rotman M, Galask R, Mac K, Soll DR, (1994) Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J Clin Microbiol 32: 2646-2654.
23. Forche A, Magee PT, Selmecki A, Berman J, May G, (2009) Evolution in Candida albicans populations during a single passage through a mouse host. Genetics 182: 799-811.
24. Cheng S, Clancy CJ, Zhang Z, Hao B, Wang W, et al. (2007) Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol 9: 492-501.
25. Lionakis MS, Lim JK, Lee CC, Murphy PM, (2011) Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun 3: 180-199.
26. Spellberg B, Ibrahim AS, Edwards JE Jr, Filler SG, (2005) Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis 192: 336-343.
27. MacCallum DM, Odds FC, (2005) Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 48: 151-161.
28. Gillum AM, Tsay EY, Kirsch DR, (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.
29. Liu H, Kohler J, Fink GR, (1994) Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726.
30. Rupniak HT, Rowlatt C, Lane EB, Steele JG, Trejdosiewicz LK, et al. (1985) Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst 75: 621-635.
31. Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, et al. (2005) Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol 7: 499-510.
32. Ebert D, (1998) Experimental evolution of parasites. Science 282: 1432-1435.
33. Papadimitriou JM, Ashman RB, (1986) The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J Pathol 150: 257-265.
34. Netea MG, Brown GD, Kullberg BJ, Gow NA, (2008) An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6: 67-78.
35. Ashman RB, (2008) Protective and pathologic immune responses against Candida albicans infection. Front Biosci 13: 3334-3351.
36. Lin Y, Cai J, Turner JD, Zhao X, (1996) Quantification of bovine neutrophil migration across mammary epithelium in vitro. Can J Vet Res 60: 145-149.
37. Romani L, Mencacci A, Cenci E, Spaccapelo R, Toniatti C, et al. (1996) Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 183: 1345-1355.
38. Natarajan U, Randhawa N, Brummer E, Stevens DA, (1998) Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole. J Med Microbiol 47: 359-363.
39. MacCallum DM, Castillo L, Brown AJ, Gow NA, Odds FC, (2009) Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One 4: e6420.
40. Djeu JY, (1990) Role of tumor necrosis factor and colony-stimulating factors in phagocyte function against Candida albicans. Diagn Microbiol Infect Dis 13: 383-386.
41. Brown DH Jr, Giusani AD, Chen X, Kumamoto CA, (1999) Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene. Mol Microbiol 34: 651-662.
42. Elena SF, Lenski RE, (2003) Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat Rev Genet 4: 457-469.
43. Ensminger AW, Yassin Y, Miron A, Isberg RR Experimental evolution of Legionella pneumophila in mouse macrophages leads to strains with altered determinants of environmental survival. PLoS Pathog 8: e1002731.
44. Levin BR, Perrot V, Walker N, (2000) Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154: 985-997.